First Trust NYSE Arca Biotechnology Index Fund
122 hedge funds and large institutions have $1.98B invested in First Trust NYSE Arca Biotechnology Index Fund in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 59 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
38% more call options, than puts
Call options by funds: $3.51M | Put options by funds: $2.54M
9% more funds holding
Funds holding: 112 → 122 (+10)
0.57% more ownership
Funds ownership: 60.36% → 60.93% (+0.57%)
Holders
122
Holding in Top 10
9
Calls
$3.51M
Puts
$2.54M
Top Buyers
| 1 | +$322M | |
| 2 | +$28.1M | |
| 3 | +$20.4M | |
| 4 |
Goldman Sachs
New York
|
+$17.8M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.1M |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$3.54M | |
| 3 | -$3.12M | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$2.61M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.3M |